Akso Health (AHG) Change in Receivables (2019)
Akso Health (AHG) reported Change in Receivables of $739757.0 for Q3 2019, up 76.71% quarter-over-quarter from $418639.0 in Q1 2019.
Akso Health (AHG) Change in Receivables (2019) Analysis & Trends
Akso Health has reported Change in Receivables for 1 years, with the latest figure at $739757.0 in Q3 2019.
- For the quarter ending Q3 2019, Change in Receivables changed N/A year-over-year to $739757.0; the trailing twelve-month figure through Sep 2019 stood at $739757.0 (changed N/A YoY), and the FY2025 full-year result was $859542.0, up 362.71% from the prior year.
- Change in Receivables for Q3 2019 stood at $739757.0, up from $418639.0 in the prior quarter.
- The five-year high for Change in Receivables was $739757.0 in Q3 2019, with the low at $418639.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -131.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -522.08 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 17.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 69.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.80 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.99 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -33,245.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 739,757.00 |
| Sep 30, 2019 | 739,757.00 |
| Mar 31, 2019 | 418,639.00 |
| Mar 31, 2019 | 418,639.00 |